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 실험에 대하여 아무것도 모른 채 의욕만 앞섰던 2002년 가을, 선약도 없이 
안영수 교수님을 찾아 뵙고 약리학 교실에서 신경과학을 전공하고 싶다고 
말씀 드렸던 것이 엊그제 같은데 벌써 6년 이라는 세월이 흘렀습니다. 
안영수 교수님의 훌륭하신 지도하에 실험이 무엇인지 연구가 무엇인지 
조금이나마 알게 되었는데, 다시 새로운 출발을 하는 위치에 서게 
되었습니다. 지도 교수님을 포함한 약리학 교실의 많은 교수님들과 선-
후배님들의 도움이 없었다면 현재의 저는 없었을 것입니다. 부족하나마 이 
지면을 통해 그 동안 표현하지 못했던 감사의 마음을 전하고자 합니다.  
무엇보다도, 과학도로의 첫 걸음을 이끌어 주신 아버지처럼 인자하시던 
안영수 교수님께 무한한 감사의 마음을 전하고 싶습니다. 교수님의 부드러운 
성품과 때로는 엄한 가르침이 과학도의 길을 포기하고 싶었던 힘든 
순간마다 저에게는 큰 힘이 되었습니다. 언제나 섬세한 부분까지 챙겨주시고, 
미래에 대한 새로운 비젼을 제시해 주시던 김경환 교수님께도 감사 
드립니다. 김동구 교수님..저에게는 지도교수님이 두 분 계시다는 생각이 
듭니다. 지도교수님 이상으로 항상 저를 아껴주시고 지도해 주시던 김동구 
교수님께도 정말 감사하다는 말씀을 전해드립니다. 학교를 대표하시는 
연구자로서 연구에 대한 식견과 안목을 넓혀주신 이민구 교수님께 감사 
드립니다. 임상시험센터를 책임 지는 막중한 위치에 계심에도 힘든 본과 
생활을 함께 보낸 기억 때문인지 늘 친근하게 대해주시는 박경수 교수님께 
감사 드립니다. 실험실 누나로 처음 뵈었지만 지금은 장래 유망한 
여성과학자이신 김주영 교수님께 감사 드립니다. 저의 사수이자 제가 힘들 
때 늘 친형처럼 따뜻하게 위로해 주시던 이진우 교수님께도 정말 감사 
드립니다. 저를 항상 인자한 미소로 맞아주시는 훌륭한 여성과학자이신 
김혜영 교수님께 감사 드립니다. 그리고 지난 2년 여간 가족보다도 더 오랜 
시간 함께하며 많은 것을 배울 수 있는 기회를 주셨던, 무엇보다도 저의 
노력과 지식의 부족함을 현실적인 눈으로 바라보게 하시어 새로운 출발의 
원동력을 제공해 주신 김철훈 교수님께 진심으로 감사 드립니다. 
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 또한 이번 졸업 논문이 나오기까지 바쁜 시간을 내어주시고 늘 조언을 
아끼지 않으셨던 연세의대 생리학 교실 김정훈 교수님과 서울의대 생리학 
교실 김상정 교수님께도 감사 드립니다. 교수님의 자문학생으로서 부끄럽지 
않은 의과학자가 되도록 노력하겠습니다. 그리고 같은 교실 소속 학생처럼 
저를 챙겨 주시는 생화학 교실의 안용호 교수님, 김경섭 교수님께도 감사 
드립니다. 학교 선배로서 많은 도움과 조언을 해 주신 생화학 교실 김하일, 
박상규 선생님께도 진심으로 감사 드립니다. 
 언제나 다정하고 친절하시던 임종수, 민선자, 김건태 선생님께도 감사 
드립니다. 약리학 교실에서 부딪히며 함께 울고 웃던 선-후배님들에게도 
감사 드립니다. 실험에 대한 열정을 본받고 싶던 임주원 교수님께도 감사 
드립니다. 처음 약리학 교실에 와서 헤매던 시절, 교실 선배로서 많은 
도움을 주시던 최지하, 남궁완, 서지혜, 유지훈, 한원선 선생님께도 감사 
드립니다. 이민구 교수님 랩의 지현이, 헌영이 그리고 이성희 선생님 및 
다른 대학원 생들에게도 감사 드립니다. 김경환-김혜영 교수님 랩 그리고 
박경수 교수님 랩 식구들 에게도 감사 드립니다. 교육 치프 시절 함께 
일했던 조교 선생님들에게도 감사 드립니다. 그리고 그 동안 힘든 일 기쁜 
일 함께 나누며 저를 도와 열심히 일해준 뉴로랩 식구들 기호, 재연, 영신이 
그리고 김영화 선생님, 김인숙 선생님 감사 합니다. 
  
어린 시절 유달리 말썽을 피우던 막내아들을 끝까지 포기하지 않으시고, 
바르고 정직한 길로 이끌어 주시는 어머니께 진심으로 감사 드립니다. 
어머니의 큰 희생으로 지금의 제가 있음을 잘 알고 있습니다. 이제는 
보답해야 할 시간이라 생각합니다. 
끝으로 어떤 선택을 하든지 저를 믿고 지지해주는 평생 동반자이자 좋은 
친구인 나의 지혜로운 아내에게 진심으로 사랑하고 고맙다는 말을 전합니다.  
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ABSTRACT 
 
Identification of a novel PKC-phosphorylation site in the 
metabotropic glutamate receptor 5 that regulates calmodulin binding, 
receptor trafficking, and downstream signaling 
 
Jeong Ho Lee 
Department of Medical Science 
The Graduate School, Yonsei University 
 
(Directed by Professor Young Soo Ahn) 
 
Metabotropic glutamate receptor 5 (mGluR5) is a G-protein couple receptor 
(GPCR) and plays an important role in synaptic plasticity, neuronal 
development, and neurodegeneration. mGluR5 is coupled to Gq protein, 
phospholipase C and protein kinase C (PKC). It has been known that the 
phosphorylation of GPCRs and consequential changes in receptor trafficking 
such as endocytosis is a typical mechanism of GPCR desensitization. Although 
PKC phosphorylation is also implicated in mGluR5 desensitization, the precise 
mechanism is not clear. In this study, a novel PKC phosphorylation site, serine 
901 (S901), in mGluR5 C-terminus was identified using phosphopeptide map 
analysis. In HeLa cells expressing mGluR5 and in primary cultured neurons, 
PKC activator PMA and mGluR5 agonist DHPG induced the phosphorylation 
of S901 in mGluR5, as detected using a S901 phosphorylation state-specific 
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antibody. In addition, agonist-induced S901 phosphorylation was inhibited by 
PKC inhibitor bisindolylmaleidmide I. S901 is located within the calmodulin 
(CaM) binding site in the mGluR5 C-terminus. Therefore, the effect of the 
phosphorylation of S901 on CaM binding was evaluated and the result showed 
that the phosphorylation of S901 by PKC inhibited the CaM binding to mGluR5. 
In Total Internal Reflection Fluorescence Microscope (TIRFM) and ELISA 
measuring cell surface mGluR5, it was found that the phosphorylation of the 
residue decreased the level of mGluR5 surface expression. Interestingly, CaM 
overexpression diminished the agonist-induced decrease of wild-type mGluR5 
surface expression, whereas CaM knock-down dramatically enhanced that of 
S901A mGluR5 which had not been changed in response to the agonist. 
Furthermore, preventing S901 phosphorylation prolonged Ca2+ oscillation 
triggered by mGluR5 activation. Therefore, our data suggest that mGluR5 
activation induces S901 phosphorylation by PKC, thereby indicating that 
agonist-induced S901 phosphorylation links CaM binding, receptor trafficking 
and downstream signaling. 
 
 
 
 
 
 
Key Word: Metabotropic glutamate receptor 5, Calmodulin, Receptor 
trafficking, PKC, Phosphorylation 
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Identification of a novel PKC-phosphorylation site in the 
metabotropic glutamate receptor 5 that regulates calmodulin binding, 
receptor trafficking, and downstream signaling 
 
Jeong Ho Lee 
Department of Medical Science 
The Graduate School, Yonsei University 
 
(Directed by Professor Young Soo Ahn) 
 
I. INTRODUCTION 
Glutamate is a major excitatory neurotransmitter and plays an 
important role in various functions of the central nervous system (CNS)1. The 
action of glutamate is mediated by the activation of glutamate receptors. There 
are two kinds of glutamate receptors. One is the ionotropic glutamate receptors 
(iGluRs) that are ion channels such as N-methyl-D-aspartate (NMDA), α-
amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA), and kinate 
receptor. The other is the metabotropic glutamate receptors (mGluRs). mGluRs, 
which consists of subtypes including mGluR1 to mGluR8, are G-protein 
coupled receptors (GPCRs) that are coupled to second messenger signaling via 
G-protein2. They are expressed on the presynaptic (e.g. mGluR7) or 
postsynaptic (e.g. mGluR5) membrane and regulate the synaptic transmission in 
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the CNS2, 3. Like other GPCRs, mGluRs have extracellular N-terminus where 
agonist can bind, seven transmembrane domain and intracellular C-terminus 
where many proteins can bind and posttranslational modification such as 
phosphorylation can occur2. mGluRs are classified into three group (e.g. Group 
I, II, and III) according to the preferred G protein and signaling pathway. 
Among them, mGluR5 belongs to Group I mGluRs that are coupled to Gq 
protein and phospholipase C (PLC) signaling pathway2. Therefore, when 
mGluR5 receptor is activated by agonist, consequentially activated PLC 
hydrolyzes phosphatidylinositol biphosphate (PIP2) into inositol triphosphate 
(IP3) and diacylglycerol (DAG). IP3 is linked to IP3 receptor and the increase of 
intracellular calcium and DAG induces the activation of protein kinase C 
(PKC)2. Then, activated PKC can phosphorylate its substrates. Functionally, 
mGluR5 is involved in the synaptic plasticity such as the formation of long-term 
depression (LTD)4 and plays an important role in several neurological diseases 
such as pain5, addiction6, and fragile X syndrome7. 
In terms of the relationship between PKC and mGluR5 function, there 
have been some electrophysiological data showing that the PKC activity 
regulates mGluR5 desensitization8. Considering that the receptor 
phosphorylation and consequent endocytosis is a typical mechanism of GPCR 
desensitization9, we can infer that mGluR5 phosphorylation by PKC might 
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affect the receptor trafficking like the internalization in a similar way as 
mGluR5 desensitization. However, there still have been lack of biochemical 
evidences of PKC phosphorylation and the desensitization mechanism by PKC 
remains unclear.  
Metabotropic glutamate receptor 5 has long intracellular C-terminal 
domain and interacts with many proteins like calmodulin (CaM), the E3 ligase 
Siah1A, Homer, and Tamalin within this region10. Among them, CaM, highly 
ubiquitous Ca2+ sensing protein11, is particularly interesting because it plays a 
key role in synaptic plasticity12 and CaM binding to mGluR5 and receptor 
phosphorylation show an antagonistic relationship13. Moreover, it has been 
known that PKC phosphorylation can induce the dissociation of CaM binding to 
other GPCRs such as mGluR714, 5-HT1A receptor15. In addition, CaM can 
regulate the trafficking of those receptors14, 16. Therefore, it is likely that PKC 
activity might affect mGluR5 functions via the regulation of CaM binding and 
receptor trafficking. 
Taken together, it can be speculated that the agonist induced 
phosphorylation of mGluR5 by PCK might affect receptor internalization as a 
desensitizing mechanism by mediating the potential interacting protein, CaM. 
The present study shows that the PKC activity directly mediates agonist-
induced serine 901 (S901) phosphorylation on mGluR5. S901 phosphorylation 
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by PKC decreases CaM binding and mGluR5 surface expression. In addition, 
CaM binding to mGluR5 stabilizes the receptor surface expression. Furthermore, 
the mutation of serine 901 to alanine (S901A) that prevents S901 
phosphorylation dramatically prolongs mGluR5-induced Ca2+ oscillation. 
Therefore, our study suggests that S901 phosphorylation by PKC affects 
mGluR5 receptor trafficking via the regulation of CaM binding and this could 
be the underlying mechanism of PKC-mediated mGluR5 desensitization.  
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II. MATERIALS AND METHODS 
 
1. DNA constructs and antibodies 
Myc-tagged mGluR5 construct was made by inserting a Myc epitope 
into the N-terminus of mGluR5 (between a.a. 22 and 23). A GST-fusion protein 
containing the C-terminus of mGluR5 was made by subcloning first one-third of 
the mGluR5 C-terminus (a.a. 828-944) into pGEX vectors (Amersham 
Biosciences, Buckinghamshire, UK). Mutations of S901 including Myc-
mGluR5 or GST-mGluR5-Cprox were made by using site-directed mutagenesis. 
The anti-Myc monoclonal antibody (9E10) was purchased from Sigma (St. 
Louis, MO, USA). Anti-His monoclonal antibody and Alexa 488- and 633-
conjugated secondary antibodies were purchased from Invitrogen (Carlsbad, CA, 
USA). Rabbit and chicken anti-mGluR5 antibodies were generated against a 
peptide corresponding to the mGluR5 C-terminus17. The S901 phosphoantibody 
was generated against the phospho-peptide N-RL[pSer]VHINKKENPNQC-C, 
and was purified using the phosphopeptide conjugated to a SulfoLink gel 
(Pierce, Rockford, IL, USA). 
 
2. Fusion protein phosphorylation and pull-down assay 
GST fusion proteins were obtained according to the manufacturer’s 
instructions (Amersham Biosciences, Buckinghamshire, UK). In vitro 
phosphorylation was performed as previously described18, 19. Briefly, GST 
fusion proteins were reacted with 25 ng of purified PKC in a reaction buffer (pH 
7.4) containing 20 mM HEPES, 1.67 mM CaCl2, 1 mM dithiothreitol, 10 mM 
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MgCl2, 10 µM cold ATP, 1 pmol of [γ-32P]ATP (3000 Ci/mmol) at 30 ºC for 30 
min. The reaction was stopped by adding the SDS-sample buffer and boiling for 
5 min. Fusion proteins were loaded on SDS-PAGE and transferred to 
nitrocellulose membranes for autoradiography. After the phosphorylated fusion 
proteins were visualized by autoradiography, the bands were excised for two-
dimensional phosphopeptide mapping. For pull-down assays, GST fusion 
proteins bound to Sepharose beads were phosphorylated as described above, but 
without adding [γ-32P]ATP. Phosphorylated fusion proteins were reacted with 
recombinant CaM (1 µg, Upstate, Lake Placid, NY, USA) in a total volume of 
500 µl of binding buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 2 mM CaCl2, 
0.5% Nonidet P-40, protease inhibitors, and phosphatase inhibitors) for 2 h at 
4°C. The beads were washed 4 times with binding buffer, and the bound 
proteins were eluted by adding SDS-PAGE sample buffer and boiling for 5 min. 
Samples resolved by SDS-PAGE were transferred to a polyvinyl difluoride 
membrane (PVDF, Millipore, Bedford, MA, USA) and visualized by Western 
blotting. The binding of CaM to phosphorylated mGluR5 was analyzed by 
immunoblotting with CaM antibody (Upstate, Lake Placid, NY, USA), and 
phosphorylation of S901 was confirmed by immunoblotting with the S901 
phosphoantibody. 
 
3. Two-dimensional phosphopeptide mapping 
Peptide mapping was performed as previously described18, 19. Briefly, 
the excised bands of phosphorylated GST-fusion proteins bound to 
nitrocellulose were soaked for 1 h in tubes containing 1 mL of 1% 
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polyvinylpyrrolidone-40 in 100 mM acetic acid. After washing with 0.4% 
NH4HCO3, the membranes were digested with 0.5 mg/mL trypsin overnight at 
37 °C. The supernatant containing digested peptides of fusion proteins were 
dried in a SpeedVac. After several washing and drying cycles, the peptides were 
dissolved in 5 µL of H2O. One or two µL of peptides were spotted onto a 
cellulose thin layer chromatography plate (Merck, Darmstadt, Germany). The 
phosphopeptides were resolved in the first dimension by electrophoresis in 
buffer containing 2.5% formic acid and 7.8% acetic acid. Separation by 
ascending chromatography in the second dimension was performed using buffer 
containing 62.5% isobutyric acid, 4.8% pyridine, 1.9% butanol, and 2.9% acetic 
acid. The thin layer chromatography plate was air-dried, and the peptide map 
was visualized using a Storm PhosphorImager (GE Healthcare, Piscataway, NJ, 
USA). 
 
4. Immunoblotting and immunoprecipitation 
Transiently transfected HeLa cells or primary cultured neurons were 
prepared as previously described20 and were lysed with 1% Triton X-100 in PBS. 
Cell lysates were immunoprecipitated with mouse anti-Myc or rabbit anti-
mGluR5 or rabbit S901 phosphorylation state-specific antibody overnight. This 
mixture was incubated with protein G or A agarose beads for 2 h. After 5 times 
washing of protein G or A agarose beads with 1% Triton X-100 in PBS, the 
beads were incubated with SDS sample buffer at 37 ºC for 10 min. The eluted 
proteins were loaded on SDS-PAGE gel and transferred to PVDF membrane. 
Immunoblotting was performed using mouse anti-His antibody (Clontech, 
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Mountain View, CA, USA), chicken anti-mGluR5 antibody, or rabbit anti-
mGluR5 antibody. 
 
5. Cell surface biotinylation assay 
HeLa cells expressing mGluR5 (wild-type, S901D or S901A) were 
rinsed three times with PBS containing 1 mM MgCl2 and 0.1 mM CaCl2 
(PBS++) and then incubated with 1 mg/mL EZ-link Sulfo-NHS-SS-Biotin 
(Pierce, Rockford, IL, USA) in PBS++ for 20 min at 4 °C. Cells were rinsed 
three times with cold 50 mM glycine in PBS++ to quench unreacted biotin. 
Cells were lysed in PBS containing 1% Triton X-100 and protease inhibitor 
cocktail (Roche, Indianapolis, IN, USA) for 10 min at room temperature. Cell 
lysates were centrifuged at 13,000x g for 10 min. The supernatant was 
incubated with neutravidin agarose beads (Pierce, Rockford, IL, USA) for 2 h at 
4 °C and washed four times with PBS containing 1% Triton X-100. Precipitates 
were eluted and analyzed by immunoblotting with the rabbit anti-mGluR5 
antibody. 
 
6. shRNA CaM knock-down 
Three distinct human CaM genes encode proteins with an identical 
amino acid sequence21. Because relative transcriptional activity of each 
calmodulin gene is tissue-specific, it was necessary to select shRNA-CaMs that 
effectively suppress the expression of CaM in HeLa cells. Three pLKO.1-puro 
shRNA plasmid target sets directed against human Calm1 (GenBank accession 
number NM_006888), Calm2 (GenBank accession number NM_001743), 
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Calm3 (GenBank accession number NM_005184), and Non-Target shRNA 
plasmid were obtained from MISSION shRNA Libraries (Sigma, St. Louis, MO, 
USA). Each shRNA plasmid target set consists of five individual shRNA clones 
containing different target sequences. HeLa cells were grown to ~40% 
confluency on 12 well culture plates. We transfected 0.8 µg of each of the 
fifteen individual shRNA plasmids into HeLa cells using Lipofectamine 2000 
(Invitrogen, Carlsbad, CA, USA). Forty-eight hours later, whole cell lysates 
were prepared. The amount of endogenous CaM in cell lysates was evaluated by 
immunoblotting with anti-CaM antibody (Abcam, Cambridge, UK). Among 
these clones, we selected the most effective clones for each CaM gene silencing. 
Optimal shRNA clones targeting CaM 2 and 3 were found. The target sequences 
are 5’-GCAGAGTTACA GGACATGATT-3’ (Calm2) and 5’-
GCCAGGTCAATTATGAAGAGT-3’ (Calm3). A mixture of equal amounts of 
these two clones was used to suppress CaM expression. We used the Mission 
non-target shRNA as a negative control. For immunoblotting, we transfected 0.8 
µg of shCaM plasmid into HeLa cells grown on 12 well tissue culture dishes. 
For ELISA experiments, we transfected 0.2 µg of Myc-mGluR5 wild-type or 
Myc-mGluR5 S901A plasmids and mixture of 0.2 µg of each shRNA against 
Calm2 and Calm3 plasmid into HeLa cells grown on 24 well tissue culture 
dishes. 
 
7. Total internal reflection fluorescence microscopy (TIRFM) 
HeLa cells transiently expressing mGluR5-mRFP wild-type or 
mGluR5-mRFP S901A were grown to ~30% confluency on 40-mm glass 
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bottom culture dishes (MatTek, Ashland, MA, USA), washed in modified HBSS 
(140 mM NaCl, 10 mM HEPES, 11 mM glucose, 5 mM KCl, 1 mM MgCl2, 1 
mM CaCl2), and allowed to equilibrate for at least 30 min at 37ºC prior to 
imaging. TIRFM was carried out using Nikon TIRF-2 w/ TE2000-PFS and 
Chamber System (Nikon, Tokyo, Japan) and its temperature-controlled chamber 
was set at 37°C for live cell imaging.  mGluR5-mRFP was excited with the 
532 nm laser and illumination intensity was attenuated as needed by a neutral 
density (ND) filter. Incident illumination passing through the Apo TIRF 100×, 
1.49NA oil-immersion objective was angled to obtain TIRF images. The 
emitted fluorescence was captured by a Hamamatsu C9100-12 Camera System 
(Hamamatsu photonics, Hamamatsu, Japan). Prior to adding 500 µM (final 
concentration) of L-glutamate dissolved in modified HBSS, the Perfect Focus 
System (PFS) unit (Nikon, Tokyo, Japan) was turned on to correct the focus 
drift caused by the addition of any reagents. MetaMorph 6.0 software 
(Universal Imaging Corp., Downingtown, PA, USA) was used for image 
analysis. Data are presented as the percentage of integrated optical density of 
spots at each time point divided by the integrated optical density at Time 0. 
Images were acquired every 3 sec for 10 min with a 100 msec exposure time. 
 
8. ELISA for quantification of receptor surface expression 
HeLa cells were grown to ~60% confluency on 24-well tissue culture 
dishes and transfected with Myc-mGluR5 wild-type or Myc-mGluR5 S901A. 
After 36~48 h, cells were washed in modified HBSS (see above) and allowed to 
equilibrate for at least 30 min at 37°C. Cells were treated with 500 µM L-
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glutamate for the indicated time intervals. The cells were washed, fixed with 4% 
paraformaldehyde in PBS for 5 min at room temperature, washed again, and 
nonspecific binding was blocked with 1% BSA/PBS for 45 min. Cells were 
incubated with Myc antibody (9E10) diluted 1:1000 in 1% BSA/PBS for 60 min, 
washed, and blocked again with 1% BSA/PBS for 15 min and incubated for 60 
min with anti-mouse IgG-HRP (Amersham Biosciences, Buckinghamshire, UK) 
diluted 1:5000 in 1% BSA. Cells were washed and incubated with the 
colorimetric horseradish peroxidase substrate, O-phenylenediamine dihydrate (1 
mg/mL; Sigma, St Louis, MO, USA) in OPD buffer (50 mM citric acid, 65 mM 
sodium phosphate, and 0.03% hydrogen peroxide, pH 5.0) with gentle shaking 
for 12 min. An equal volume of 0.1N H2SO4 was added to stop the reaction. The 
optical density of each well was determined using a microplate reader at 492 nm. 
The value obtained for untransfected cells was subtracted as background optical 
density. 
 
9. Receptor trafficking in neurons 
A fluorescence-based antibody uptake internalization assay was 
performed as previously described20 with some modifications. Cultured 
hippocampal neurons prepared from E18 Sprague Dawley rats were transfected 
with Myc-mGluR5 (wild-type or S901A) and mRFP-CaM or mRFP alone using 
calcium phosphate co-precipitation. After 48 hours, Myc antibody was added to 
media to label surface-expressed mGluR5 for 40 min. Neurons were washed 
with PBS twice and then treated with 100uM of group I mGluR agonist DHPG 
for 30 min at 37°C or with conditioned media alone. After washing with PBS, 
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the cells were fixed with 4% paraformaldehyde/4% sucrose in PBS for 15 min.  
Neurons were incubated with Alexa 633-conjugated (red) anti-mouse secondary 
antibody (Molecular Probes, Carlsbad, CA, USA) for 30 min at room 
temperature for staining the surface receptors, and were permeabilized with 
0.25% Triton X-100 for 5 min.  After blocking with 10% normal goat serum, 
the neurons were incubated with Alexa 488-conjugated (green) anti-mouse 
secondary antibody (Molecular Probes, Carlsbad, CA, USA) for 30 min to label 
intracellular pools of receptors.  After washing with PBS, ProLong Antifade 
reagent (Molecular Probes, Carlsbad, CA, USA) was applied to neurons prior to 
mounting.  Images were analyzed with a 40x objective on a Zeiss LSM 510 
confocal microscope. Alexa 488 dye was excited with a 488 nm Ar laser and 
appeared green. The Alexa 633 dye (excited with a 633 nm HeNe laser) was 
presented as red for clarification. mRFP (Invitrogen, Carlsbad, CA, USA) was 
excited with a 543 nm HeNe laser and presented as white. No cross talk 
between channels was detected under these settings. Series of optical sections 
were collected at intervals of 0.4 µm. Figures show maximum projections. For 
quantitative analysis, images from three or four dendrites per neuron (at least 
fifteen neurons per experiment) were collected, and the amount of 
internalization was measured based on the data collected in three independent 
experiments with MetaMorph 6.0 software (Universal Imaging Corp., 
Downingtown, PA, USA).   
 
10. Statistics 
Data were analyzed with Student’s unpaired t-test or one-way ANOVA 
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and subsequent Tukey-Kramer test. Statistical significance was accepted at *p 
<0.05 or **p <0.01. P-values were presented with F value and degree of 
freedom as needed. Results were reported as mean ± SEM or ± SD as indicated.  
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III. RESULTS 
 
1. Serine 901 (S901) phosphorylation by PKC in heterologous cells 
In order to find out new PKC phosphorylation site on mGluR5-C 
terminus, GST-fusion protein containing the proximal portion (a.a. 828-944) of 
mGluR5 C-terminus (GST-mGluR5-Cprox) were generated. Then, they were 
incubated with PKC and [γ-32P] ATP in vitro and the phosphorylation status was 
measured using two dimensional phosphopeptide map analysis. It was found 
that there were several PKC phosphorylation sites (Fig. 1A). However, when 
serine 901 (S901) was mutated to alanine (S901A), it was observed that the 
most prominent phosphorylated peptide was eliminated (Fig. 1A). Next, S901 
phosphorylation state-specific antibody was generated and confirmed by 
immunoblotting with PKC-phosphorylated fusion protein (GST-mGluR5 Cprox 
wild-type or S901A) (Fig. 1B). Then, it was examined whether S901 could be 
phosphorylated by PKC in cells. After Myc-tagged mGluR5 wild-type (WT) or 
S901A were transfected into HeLa cell, these cells were treated with PKC 
activator, PMA, and mGluR5 agonist, DHPG. The immunoprecipitation was 
performed from cells lysates using anti-myc antibody and it was observed that 
PMA and DHPG increased the S901 phosphorylation in mGluR5 WT using 
S901 phosphorylation state specific antibody, not in mGluR5 S901A (Fig. 1C-
F)  
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FIGURE 1. Serine 901 (S901) on mGluR5 is phosphorylated by PKC in 
HeLa cells. (A) GST-mGluR5-Cprox wild-type and GST-mGluR5-Cprox 
S901A were incubated with PKC and [γ-32P] ATP in vitro. Phosphorylation 
status was measured using two-dimensional phosphopeptide mapping analysis. 
(B) GST-mGluR5-Cprox wild type and S901A were phosphorylated by PKC in 
vitro and S901 phosphorylation was detected using immunoblotting with S901 
phosphorylation state-specific antibody generated in our laboratory. (C-F) Myc-
mGluR5 wild-type or Myc-mGluR5 S901A was transfected into HeLa cells. 
They were treated with PMA (1 µM) or DHPG (100 µM) as indicated. Cell 
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lysates were immunoprecipitated with Myc antibody and S901 phosphorylation 
was measured by immunoblotting with S901 phosphoantibody. Quantification 
of immunoblotting (D and F) was shown as a histogram (n=3). Statistical 
significance is indicated as **p< 0.01
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2. S901 phosphorylation by PKC in neurons 
Next, it was examined whether PMA and DHPG can also induce S901 
phosphorylation of endogenous mGluR5. Primary cultured neurons were treated 
with PMA and DHPG and then phosphorylated receptors were 
immunoprecipitated using S901 phosphorylation state specific antibody both in 
denaturing and non-denaturing condition. It was found that PMA and DHPG 
dramatically induced S901 phosphorylation (Fig. 2A-D). Moreover, it was also 
found that PCK specific inhibitor, bisindolymaleimide I (Bis I), prevented the 
DHPG induced S901 phosphorylation of endogenous mGluR5 (Fig. 2E). 
Therefore, these data indicate that the agonist induced S901 phosphorylation of 
mGluR5 is mediated by PKC. 
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FIGURE 2. S901 on mGluR5 is phosphorylated by PKC in neurons. (A-B) 
Cultured cortical neurons were treated with PMA (1 µM) for 10min. Neuronal 
lysates were immunoprecipitated with S901 phosphospecific antibody both in 
non-denaturing and denaturing condition. Then, S901 phosphorylated mGluR5 
was measured using immunoblotting with mGluR5 antibody. (C-D) Cultured 
neurons were treated with DHPG (100 µM) for 10min. Phosphorylated 
receptors were immunoprecipitated with S901 phosphospecific antibody and 
measured using immunoblotting with mGluR5 antibody. (E) Cultured neuron 
preincubated with bisindolylmaleimide I (Bis I, 5 µM for 30 min) were treated 
with DHPG (100 µM for 10min). S901 phosphorylated mGluR5 was 
immunoprecipitated and then measured with mGluR5 antibody. Quantification 
of immunoblotting (B and D) was shown as a histogram (n=3). Statistical 
significance is indicated as **p< 0.01 
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3. S901 phosphorylation induced dissociation of CaM-mGluR5 interaction 
Calmodulin (CaM) is highly ubiquitous Ca2+ sensing proteins in the 
cytoplasm. In the CNS, CaM is involved in synaptic plasticity12. The reason that 
CaM was studied is because it has been known that the phosphorylation of 
mGluR5 by PKC and CaM binding shows the antagonistic relationship13. In that, 
mGluR5 phosphorylation by PKC prevents CaM binding to mGluR5. More 
interestingly, S901 is located within CaM binding site on mGluR5 (Fig. 3A). In 
order to examine whether S901 phosphorylation by PKC can affect CaM 
binding to mGluR5, GST-full down assay was performed and it was found that 
S901 phosphorylation by PKC dramatically inhibited CaM-mGluR5 WT 
interaction (Fig. 3B-C). However, CaM-mGluR5 S901A interaction was not 
affected by PKC treatment. It was also found that the addition of EGTA 
completely prevented CaM binding to mGluR5, suggesting that CaM-mGluR5 
interaction is Ca2+ dependent (Fig. 3B). Furthermore, co-immunoprecipitation 
was performed from full-length mGluR5 and CaM expressing HeLa cells. It 
was found that the mutation S901 to aspartic acid (S901D), a phosphomimetic 
mutation, significantly inhibited CaM binding to full-length mGluR5 (Fig. 3D-
E). These data suggest that S901 phosphorylation plays a key role in regulating 
CaM binding to mGluR5. 
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FIGURE 3. S901 phosphorylation inhibits CaM binding to mGluR5. (A) A 
cartoon shows that S901 is located within CaM-binding site on the mGluR5 C-
terminus (B-C) GST-mGluR5 Cporx wild-type or S901A was treated with PKC 
and incubated with recombinant CaM in the addition of 2mM CaCl2 or 5mM 
EGTA. The binding of CaM to phosphorylated mGluR5 was measured by 
immunoblotting with CaM antibody. S901 phosphorylation by PKC was 
analyzed using S901 phsophospecific antibody. Quantification of 
immunoblotting was shown as a histogram (n=4). (D-E) His tagged CaM and 
various mGluR5 constructs (wild-type, S901D, or S901A) were co-transfected 
into HeLa cells. Cell lysates were immunoprecipitated with mGluR5 antibody 
and His-CaM binding to mGluR5 was measured by immunoblotting with His 
antibody. Quantification of immunoblotting was shown as a histogram (n=3). 
Statistical significance is indicated as **p < 0.01 [F(2, 6)=47.95] 
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4. Role of S901 phosphorylation in the trafficking of mGluR5 in 
heterologous cells 
As mentioned earlier, receptor phosphorylation and consequent 
endocytosis is a typical mechanism of GPCR desensitization. Therefore, it is 
likely that S901 phosphorylation can affect the internalization of mGluR5. It 
was examined whether S901 phosphorylation could regulate the trafficking of 
mGluR5. The trafficking of mGluR5 on the plasma membrane of HeLa cells 
expressing mRFP-tagged mGluR5 was monitored in real-time using TIRFM. It 
was observed that fluorescence spots of mGluR5 WT were disappeared in 
response to the glutamate (Fig. 4A), consistent with the agonist induced 
endocytosis of mGluR5. However, when these fluorescence spots were 
analyzed using MetarMorph software and compared mGluR5 WT to S901A, it 
was found that fluorescence spots of mGluR5 S901A did not change over the 
time in response to the agonist (Fig. 4B). In addition, using ELISA assay for 
surface receptor, it was observed that the agonist treatment induced the decrease 
of mGluR5 WT surface expression, not mGluR5 S901A (Fig. 4C). Using 
surface biotinylation assay, it was also found that the surface expression level of 
mGluR5 was significantly decreased in HeLa cells expressing mGluR5 S901D 
mutant, mimicking the phosphorylation of entire pool of mGluR5, compared to 
mGluR5 WT (Fig. 4D-E). These data demonstrate that the agonist induced S901 
phosphorylation regulates the internalization and surface expression level of 
mGluR5. 
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FIGURE 4. S901 phosphorylation regulates the trafficking of mGluR5 in 
HeLa cells. (A) In response to glutamate (500 µM), the trafficking of mGluR5 
on the membrane of HeLa expressing wild-type mGluR5-mRFP was monitored 
over time using total internal reflection fluorescence microscopy (TIRFM). (B) 
After glutamate treatment, changes of mGluR5 wild-type and S901A 
fluorescence were monitored over time by TIRFM and analyzed by MetaMorph 
software. Total optical densities of mGluR5 wild-type and S901A fluorescence 
are presented in a line graph. (C) Changes of Myc tagged mGluR5 wild-type or 
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S901A surface expression following -/+ glutamate addition were measured 
using ELISA for surface receptor. The expression levels are presented in a line 
graph. *p < 0.05 [F(3, 20)=4.68], **p < 0.01 [F(3, 23)=12.63] compared with 
S901A + glutamate (D-E) The expression of surface mGluR5 (wild-type, 
S901D, or S901A) in HeLa was analyzed by biotinylation assay. Biotin-labeled 
membrane proteins were isolated from cell lysates using neutravidin agarose 
and then analyzed by immunoblotting with mGluR5 or actin antibodies. 
Quantification of immunoblotting was shown as a histogram. **p < 0.01 [F(2, 
12)=4.55] compared with mGluR5 wild-type 
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5. Role of CaM binding in the trafficking of mGluR5 in heterologous cells 
When it is considered that S901 phosphorylation regulates CaM binding 
to mGluR5, it needs to be examined whether changes in CaM expression can 
alter the trafficking of mGluR5. First, it was evaluated whether overexpression 
and knock-down of CaM in HeLa cells can change the basal surface expression 
level of mGluR5. It was found that changes in CaM expression did not affect 
the basal surface expression of mGluR5 (Fig. 5A). However, CaM 
overexpression inhibited the agonist induced decrease of mGluR5 WT surface 
expression (Fig. 5B). Moreover, knock-down of CaM dramatically decreased 
the agonist-induced surface level of mGluR5 S901A (Fig. 5C). Taken together 
with the previous data, these data demonstrate that the mGluR5 trafficking and 
the agonist induced decrease of mGluR5 surface expression is due to the agonist 
induced S901 phosphorylation and consequent CaM dissociation. 
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FIGURE 5. Changes of CaM expressions alter the trafficking of mGluR5 in 
HeLa cells. (A) Myc tagged mGluR5 construct and CaM or shRNA targeting 
CaM (shCaM) were co-transfected into HeLa cells. Surface expression of 
mGluR5 was measured by ELISA for surface receptor with Myc antibodies. The 
knockdown of endogenous CaM by shCaM was confirmed using 
immunoblotting with CaM and actin antibodies (Inset). (B-C) HeLa cells 
expressing Myc-mGluR5 (wild-type or S901A) with -/+ CaM (B) or -/+ shCaM 
(C) were treated with glutamate. Surface expression of mGluR5 was evaluated 
by ELISA over time. Changes of surface expression were presented as a line 
graph (B) *p < 0.05 [F(3, 83)=23.83 for 10 min], **p < 0.01 [F(3, 88)=17.19 
for 20min, F(3, 84)=49.55 for 40min] compared with WT + glutamate. (C) **p 
< 0.01 [F(3, 76)=18.75 for 10 min, F(3, 76)=19.58 for 20min, F(3, 76)=12.84 
for 40 min] compared with S901A + glutamate. 
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6. Role of S901 phosphorylation and CaM binding in the trafficking of 
mGluR5 in neurons 
Next, it needs to be examined whether S901 phosphorylation and CaM 
binding can affect the trafficking of mGluR5 in hippocampal neurons. In order 
to measure the receptor trafficking in neurons, fluorescence-based antibody 
uptake assay was performed. In this assay, green spots mean the internalized 
mGluR5, whereas red spots mean the surface expressed mGluR5 (Fig. 6A). It 
was found that the DHPG treatment significantly induced the internalization of 
mGlu5 in hippocampal neurons (Fig. 6A). Using this technique, the agonist 
induced internalization of mGluR5 S901A was compared to that of mGluR5 
WT. It was found that the agonist induced internalization of mGluR5 S901A 
was significantly decreased (Fig. 6B-C). Moreover, It was found that co-
transfection of CaM decreased the agonist induced internalization of mGluR5 
WT (Fig. 6B-C). Therefore, these findings demonstrate that S901 
phosphorylation and CaM binding is a key mechanism regulating the agonist 
induced internalization of mGluR5 both in heterologous cells and neurons. 
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FIGURE 6. Agonist induced internalization of mGluR5 is regulated by 
S901 phosphorylation and CaM binding in neurons. (A) Culture 
hippocampal neurons expressing Myc-mGluR5 were preincubated with Myc 
antibody for 45 min. After the treatment of DHPG (100 µM) for 30 min, the 
surface receptors were labeled with red fluorescence, whereas the internalized 
receptors with green fluorescence (details in Materials and Methods). 
Fluorescence-labeled receptors were visualized by confocal micrscopy. Merged 
images are presented on the bottom. (B) Myc-mGluR5 wild-type or S901A with 
CaM-mRFP or mRFP only were co-transfected into hippocampal neurons. After 
treatment of DHPG, the surface and internalized receptors were visualized as 
indicated. mRFP signals were presented as white for clarification. (C) 
Quantification of confocal imaging was shown as a histogram. Y-axis indicates 
the ratio of the internalized receptors among the total receptors. **p < 0.01. 
(n=180 for DHPG group, n=40 for Control group)
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7. Role of S901 phosphorylation in the downstream signaling of activated 
mGluR5 
Finally, it was examined whether S901 phosphorylation can affect the 
mGluR5 signaling. It has been well known that the activated mGluR5 by the 
agonist triggers Ca2+ oscillation22. Moreover, it has been also known that the 
frequency of Ca2+ spike is correlated with the mGluR5 receptor density on the 
plasma membrane23. Using fura-2-AM and ratiometric spectrofluoremeter, it 
was found that the agonist treatment induced Ca2+ oscillation in mGluR5 WT 
expressing HeLa cells (Fig. 7A). The frequency of Ca2+ spike (14.27 ± 3.49 
mHz) and the half time of Ca2+ to return to the prestimulated level (151.54 ± 
112.83 s) in mGluR5 WT expressing HeLa cells (Fig. 7C and 7E) were also 
measured. However, in mGluR5 S901A expressing HeLa cells, the frequency of 
Ca2+ spike was significantly increased as 26.75 ± 7.70 mHz and the half time of 
Ca2+ to return to the prestimulated level was dramatically prolonged as 886.85 ± 
236.97 s (Fig. 7B, 7D, and 7F). Therefore, these data indicate that the agonist 
induced signaling of mGluR5 S901A is severely prolonged, compared to that of 
mGluR5 WT. This is consistent with that the prevention of S901 
phosphorylation inhibits the desensitization of mGluR5 signaling.  
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FIGURE 7. S901 phosphorylation regulates the frequency and half time of 
Ca2+ oscillation in mGluR5 expressing HeLa cells. (A-B) Typical examples of 
agonist-induced Ca2+ oscillation pattern in mGluR5 wild-type (A) or S901A (B) 
expressing HeLa cells were shown. Ca2+ oscillations were analyzed using fura-
2AM and ratiometric spectrofluorophotometer. (C-D) The frequency of Ca2+ 
spikes was measured in mGluR5 wild-type or S901A expressing HeLa cells. 
Data are represented as a histogram (n=27 for wild-type; n=23 for S901A). (E-
F) The half-time of Ca2+ spikes returning to pre-stimulated level was measured 
and presented as a histogram (n=27 for wild-type; n=20 for S901A). 
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IV. DISCUSSION 
In the present study, the novel PKC phosphorylation site, S901 on 
mGluR5 C-terminus was identified. Agonist-induced mGluR5 activation and 
PKC activity regulated S901 phosphorylation, which profoundly inhibited CaM 
binding to mGluR5. Importantly, agonist-induced S901 phosphorylation 
decreased mGluR5 surface expression. It was also shown that S901 
phosphorylation and consequential changes in receptor trafficking were 
mediated by CaM, whose binding to mGluR5 stabilized the surface expression 
of mGluR5. Furthermore, it was found that agonist-stimulated mGluR5 
signaling in mGluR5 S901A was severely prolonged, indicating that preventing 
S901 phosphorylation inhibits the desensitization of mGluR5 induced by 
agonist. Therefore, it can be speculated as a hypothetical model that CaM 
binding stabilizes mGluR5 surface expression, but agonist induced S901 
phosphorylation by PKC and consequent CaM dissociation decrease mGluR5 
surface expression (Fig. 8). 
There have been evidences that the direct phosphorylation of S839 on 
mGluR5 C-terminus plays an important role in regulating Ca2+ oscillations that 
are PKC dependent19, 22. The present study suggests that S901 is another key 
phosphorylation site that regulates the frequency and duration of Ca2+ 
oscillations. In addition, our data strongly indicate that the decrease of mGluR5 
surface expression by S901 phosphorylation is the underlying mechanism of 
PKC mediated mGluR5 desensitization.  
CaM is a universal Ca2+ sensor protein ubiquitously expressed in most 
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eukaryotic cells, which relay Ca2+ mediated intracellular signaling11. Especially, 
it is highly abundant in brain24 and enriched in postsynaptic density25 and 
synaptic vesicles26 of neurons, thereby regulating ion channel function27, 28, 
GPCR signaling29-31, and synaptic plasticity27, 28, 31. Intriguingly, there have been 
accumulating evidences suggesting that CaM directly interacts with various 
GPCRs expressed in neurons such as dopamine29, opioid32, serotonin15, 30, and 
metabotropic glutamate receptors (mGluRs)13, 33. In some cases, CaM is 
involved in the GPCR trafficking. For examples, CaM binding to mGluR7 
disrupts its interaction with PDZ protein PICK1, increasing the internalization 
of the receptor14 and the agonist-induced endocytosis of 5-HT1A receptor is 
prevented by CaM inhibitor16. In addition, there are some evidences that CaM 
regulates the function of G protein-coupled receptor kinases, which are 
implicated in endocytosis of GPCRs, indicating a possible role of CaM in 
regulating GPCR trafficking34, 35. Therefore, when it comes to the dynamic 
regulation of GPCR trafficking by CaM binding, this study shows the direct 
evidences that CaM stabilizes mGluR5 surface expression. 
As mentioned earlier, CaM is highly ubiquitous and abundant proteins. 
Although GPCRs such as mGluR5 and mGluR7 can be expressed together in 
one neuron, the trafficking of receptors are regulated by CaM in an opposite 
way. Then, how can different functions of CaM in each GPCR be explained? 
Various stimuli including the activation of Gq-coupled metabotropic and 
tyrosine kinase receptors can induce the activation of protein kinase Cs (PKCs) 
that is crucial for synaptic plasticity36. The activation of PKC is especially 
implicated in the phosphorylation of various CaM binding GPCRs including 5-
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HT1A and 5-HT2A receptor15, 30, mGluR513, and mGluR733. The phosphorylation 
of CaM binding sites by activated PKC can induce the dissociation of CaM 
binding from its target GPCRs. For example, the phosphorylation on GPCRs 
such as 5-HT1A receptor15, mGluR513 and mGluR733 by PKC and CaM binding 
to receptors are antagonistic. Moreover, CaM binding can affect the interaction 
of GPCRs with other binding proteins. For example, CaM binding site on 
mGluR5 overlays Siah-1A binding sites10. CaM and Siah-1A competitively bind 
to mGluR5 C-terminus37. In addition, CaM binding to mGluR7 competitively 
decreases the PICK1 binding14. In that, the phosphorylation of GPCRs by PKC 
and consequential dissociation of CaM from receptors can allow the binding of 
other interacting proteins such as Siah-1A and PICK1. 
Siah-1A can be a highly possible candidate as a major regulator, 
enhancing the internalization of mGluR5. Siah-1A, E3 ubiquitin ligase, 
induces the ubiquitination and degradation of its substrates including mGluR1 
and mGluR538. Recently, it has been known that several E3 ubiquitin ligases 
such as Mdm2 and Cbl can be implicated both in the mono- or 
poylubiquitination39. The monoubiquitination of membrane receptors such as 
receptor tyrosine kinases (RTKs) and α-factor receptor plays a role in the 
receptor trafficking by enhancing the internalizing and lysosomal degradation 
of receptors40, 41. Siah-1A also can promote the monoubiquitination of α-
synuclein42. Therefore, it is likely that agonist-induced phosphorylation of 
mGluR5 dissociates CaM binding and may enhance Siah-1A binding to the 
receptor and Siah-1A then may increase the internalization and degradation of 
mGluR5 as a major regulator. On the other hand, PICK1 is a PDZ and BAR 
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domain containing proteins that bind to AMPA receptor subunits such as 
GluR2 and GluR343. It has been known that PICK1 is a key regulator of AMPA 
receptor trafficking43. In mGluR7, the PKC phosphorylation and dissociation 
of CaM enhance PICK1 binding to the receptor, thereby increasing the surface 
expression of mGluR714. Therefore, these evidences suggest that CaM may 
play a role as an integrator of the GPCRs trafficking, coordinating the binding 
of regulators to each GPCRs in response to the receptor phosphorylation by 
PKC.  
Increasingly, it is becoming evident that CaM interacts with numerous 
GPCRs such as vasopressin and angiotensin receptor, as well as GPCRs specific 
in neurons44-46. This study is the first evidence to describe the dynamic 
regulation of GPCR trafficking by CaM binding in living cells. In spite of the 
rapid recent progress in dissecting the functional role of CaM in GPCRs, the 
role of CaM as an integrator of GPCRs trafficking still remains unanswered 
regarding the major regulators that control each GPCRs trafficking and 
signaling combined with the dissociation of CaM. Therefore, the identification 
of GPCRs interacting proteins that are antagonistic to CaM binding may 
provide a mechanistic linking between the phosphorylation and trafficking and 
signaling of GPCRs. I believe that the current scientific interests in these topics 
will be answered in the near future. 
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FIGURE 8. Hypothetical model of the PKC-CaM that regulates mGluR5 
trafficking. The model that competition between PKC phosphorylation of S901 
and CaM binding to mGluR5 regulates receptor trafficking can be speculated 
(Left). CaM binding to mGluR5 stabilizes receptor surface expression (Middle). 
However, S901 phosphorylation by PKC prevents CaM binding and enhances 
the internalization of receptor (Right). 
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V. CONCLUSION 
The present study shows the direct mechanistic link between PKC 
phosphorylation of mGluR5, CaM binding, receptor trafficking, and 
downstream signaling. We concluded that: 
 
1. The agonist-induced S901 phosphorylation on mGluR5 is mediated 
by PKC. 
 
2. S901 phosphorylation is a critical mechanism regulating CaM 
binding to mGluR5. 
 
3. S901 phosphorylation and CaM binding regulate mGluR5 receptor 
trafficking. 
 
4. S901 phosphorylation regulates Ca2+ oscillation frequency and 
decay time.  
 
This study demonstrates that CaM plays a role in regulating the 
binding activities of glutamate receptor-interacting proteins and the receptor 
functions. These are consistent with the possible role of CaM as an integrator or 
modulator of glutamate receptor-induced synaptic plasticity. As shown here, 
CaM will dynamically regulate receptor expression and mGluR5-mediated 
synaptic plasticity in vivo as well. 
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 ABSTRACT (IN KOREA) 
 
Metabotropic glutamate receptor 5 에서 calmodulin 결합, 수용체 
trafficking 그리고 downstream signaling을 조절하는 새로운 PKC 
인산화 위치 규명  
 
지도교수 안 영 수 
연세대학교 대학원 의과학과 
이 정 호 
 
Metabotropic glutamate receptor 5 (mGluR5)는 G 단백 연결 
수용체로서 신경가소성, 신경발달 및 퇴행성 신경질환에 중요한 
역할을 하며, 신호전달과 관련하여 Gq 단백과 연관되어 phospholipase 
C 와 protein kinase C (PKC)를 활성화 시키는 것으로 알려져 있다. G 
단백 연결 수용체의 중요한 민감소실(desensitization) 기전에는 수용체 
인산화와 그 결과로 나타나는 세포 내 이입(endocytosis)과 같은 
수용체 trafficking 이 있다. PKC 의 활성화가 mGluR5 의 민감소실과 
관련이 있는 것으로 알려져 있으나 현재 그 정확한 기전을 알려져 
있지 않다. 본 연구에서는 phosphopeptide mapping 분석을 통하여 
mGluR5 세포 내 C-말단 부위에 있는 serine 901(S901)이 PKC 의하여 
인산화 됨을 확인하였다. mGluR5 를 발현하는 HeLa 세포와 일차 
배양한 신경세포 모두에서 PKC 활성제인 PMA 와 mGluR5 효현제인 
DHPG 를 처리하였을 때 S901 인산화가 유도됨을 S901 인산화 항체를 
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이용하여 확인하였다. 또한 PKC 억제제인 bisindolylmaleimide I 을 
세포에 처리한 경우 mGluR5 효현제에 의해 유도되는 S901 인산화가 
억제됨을 확인하였다. 흥미롭게도 S901 은 mGluR5 C-말단에 위치한 
calmodulin(CaM) 결합 부위에 위치하고 있다. 따라서 CaM 의 결합이 
S901 인산화에 의해 조절되는지를 살펴보았다. PKC 에 의한 S901 
인산화에 의해 CaM 과 mGluR5 와 결합이 억제되는 것이 관찰되었다. 
Total Internal Reflection Fluorescence Microscope (TIRFM)와 ELISA 를 
이용한 실험에서 S901 인산화가 mGluR5 의 세포막 발현을 
감소시키는 결과를 얻었다. 또한 CaM 을 과발현(overexpression) 시킨 
경우 효현제에 의한 mGluR5 세포막 발현 감소가 억제 되나, CaM 을 
knock-down 시킨 경우 효현제에 의해 별 변화가 없던 S901A mutant 
mGluR5 세포막 발현을 크게 감소시킨 것을 확인 하였다. 더 나아가 
S901 인산화를 봉쇄한 경우 Ca2+ oscillation 을 지속시킴으로써 mGluR5 
신호전달에 영향을 주는 것을 확인하였다. 따라서 이상의 결과를 
통해서 볼 때, 활성화된 mGluR5 는 PKC 를 통하여 S901 인산화를 
유도하고 이것은 PKC를 통한 인산화, CaM 결합, 수용체 trafficking과 
신호전달을 직접적으로 연결하는 중요한 역할을 함을 알 수 있었다.  
 
 
 
 
핵심되는 말: Metabotropic glutamate receptor 5, Calmodulin, Receptor 
trafficking, PKC, Phosphorylation
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